Men's Health Videos

Men's Health Latest News

Early Adjuvant Radiotherapy Benefits Selected Prostate Cancer Patients

Early Adjuvant Radiotherapy Benefits Selected Prostate Cancer Patients

Radiotherapy given within 6 months of radical prostatectomy reduces cancer-specific mortality in men with highly aggressive disease.

Erectile Dysfunction (ED) Drug Taken 15 Minutes Before Sexual Activity Approved

Erectile Dysfunction (ED) Drug Taken 15 Minutes Before Sexual Activity Approved

FDA has approved a supplemental new drug application for Stendra (avanafil) taken early as ~15 minutes before sexual activity.

Radical Prostatectomy Rates Rising

Radical Prostatectomy Rates Rising

Utilization rates jumped by double digits across prostate cancer risk groups from 2004 to 2011.

Statins Reduce Prostate Cancer Recurrence Risk After Radiotherapy

Statins Reduce Prostate Cancer Recurrence Risk After Radiotherapy

This benefit is not seen in patients who undergo radical prostatectomy, according to an updated meta-analysis.

Aspirin Eases Genitourinary (GU) Toxicity from Prostate Cancer Radiotherapy

Aspirin Eases Genitourinary (GU) Toxicity from Prostate Cancer Radiotherapy

Low-dose aspirin decreased the likelihood of acute genitourinary toxicity in prostate cancer by 27%.

Genetic Variant May Predict Resistance to Prostate Cancer Drugs

Genetic Variant May Predict Resistance to Prostate Cancer Drugs

Enzalutamide and abiraterone may not benefit men with metastatic castration-resistant prostate cancer who have AR-V7 in circulating tumor cells.

Men with Metabolic Aberrations Have Lower Prostate Cancer Risk

Men with Metabolic Aberrations Have Lower Prostate Cancer Risk

However, they are more likely to die from causes other than prostate cancer than men with normal metabolic levels.

FDA Approves New Indication for Enzalutamide

FDA Approves New Indication for Enzalutamide

The drug is now also approved for use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.

Brachytherapy Offers Favorable Long-Term Prostate Cancer Survival

Brachytherapy Offers Favorable Long-Term Prostate Cancer Survival

Study finds a 15-year cancer-specific survival rate of 94%; hormone therapy for more than 6 months decreases all-cause survival.

Palpable Tumors Plus Low PSA May Up Prostate Cancer Death Risk

Palpable Tumors Plus Low PSA May Up Prostate Cancer Death Risk

New study highlights the importance of digital rectal examinations in PCa patients with normal-range PSA at diagnosis.

Poor Prostate Cancer Knowledge Associated with Decision Conflict

Poor Prostate Cancer Knowledge Associated with Decision Conflict

Findings seen in economically disadvantaged men with newly diagnosed prostate cancer.

Mental Illness Develops in 20% of Elderly Prostate Cancer Patients

Mental Illness Develops in 20% of Elderly Prostate Cancer Patients

Risk is greater in patients managed with watchful waiting than in those who undergo radical treatment.

Moderate-to-Severe Lower Urinary Tract Symptoms (LUTS) Undertreated

Moderate-to-Severe Lower Urinary Tract Symptoms (LUTS) Undertreated

Only 10% of men aged 45-69 years who progress from no or mild to moderate or severe lower urinary tract symptoms are treated, study finds.

Focal Prostate Cancer Therapy Safe, Feasible

Focal Prostate Cancer Therapy Safe, Feasible

In a study, none of the 62 men who had the treatment experienced erectile dysfunction or urinary incontinence.

MRI Highly Accurate in Detecting Significant Prostate Cancer

MRI Highly Accurate in Detecting Significant Prostate Cancer

Diffusion-weighted technique found to have a sensitivity and specificity of 89%-91% and 77%-81%, respectively.

Sign Up for Free e-newsletters